{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:42:15Z","timestamp":1787226135616,"version":"build-2736575974"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disease and the leading cause of dementia worldwide. Different pathologic changes have been introduced to be involved in its progression. Although amyloid-\u03b2 (A\u03b2) deposition and tau hyperphosphorylation and aggregation are mainly considered the main characterizations of AD, several other processes are involved. In recent years, several other changes, including alterations in gut microbiota proportion and circadian rhythms, have been noticed due to their role in AD progression. However, the exact mechanism indicating the association between circadian rhythms and gut microbiota abundance has not been investigated yet. This paper aims to review the role of gut microbiota and circadian rhythm in AD pathophysiology and introduces a hypothesis to explain their association.<\/jats:p>","DOI":"10.1038\/s41514-023-00104-6","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:03:05Z","timestamp":1683025385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gut microbiota and circadian rhythm in Alzheimer\u2019s disease pathophysiology: a review and hypothesis on their association"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-0378","authenticated-orcid":false,"given":"Mohammad Rafi","family":"Khezri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"104_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/JMN:23:3:157","volume":"23","author":"JW Ashford","year":"2004","unstructured":"Ashford, J. W. APOE genotype effects on Alzheimer\u2019s disease onset and epidemiology. J. Mol. Neurosci. 23, 157\u2013165 (2004).","journal-title":"J. Mol. Neurosci."},{"key":"104_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Khachaturian","year":"1985","unstructured":"Khachaturian, Z. S. Diagnosis of Alzheimer\u2019s disease. Arch. Neurol. 42, 1097\u20131105 (1985).","journal-title":"Arch. Neurol."},{"key":"104_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMra041071","volume":"352","author":"AE Budson","year":"2005","unstructured":"Budson, A. E. & Price, B. H. Memory dysfunction. N. Engl. J. Med. 352, 692\u2013699 (2005).","journal-title":"N. Engl. J. Med."},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.410100209","volume":"10","author":"RD Terry","year":"1981","unstructured":"Terry, R. D., Peck, A., DeTeresa, R., Schechter, R. & Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184\u2013192 (1981).","journal-title":"Ann. Neurol."},{"key":"104_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers, J., Luber-Narod, J., Styren, S. D. & Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease. Neurobiol. Aging 9, 339\u2013349 (1988).","journal-title":"Neurobiol. Aging"},{"key":"104_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/BF00294425","volume":"83","author":"E Masliah","year":"1991","unstructured":"Masliah, E. et al. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer\u2019s disease. Acta Neuropathol. 83, 12\u201320 (1991).","journal-title":"Acta Neuropathol."},{"key":"104_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/glia.440020605","volume":"2","author":"TG Beach","year":"1989","unstructured":"Beach, T. G., Walker, R. & McGeer, E. Patterns of gliosis in Alzheimer\u2019s disease and aging cerebrum. Glia 2, 420\u2013436 (1989).","journal-title":"Glia"},{"key":"104_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.2000.tb05561.x","volume":"924","author":"JQ Trojanowski","year":"2000","unstructured":"Trojanowski, J. Q. & LEE, V. M. Y. \u201cFatal attractions\u201d of proteins: a comprehensive hypothetical mechanism underlying Alzheimer\u2019s disease and other neurodegenerative disorders. Ann. N. Y. Acad. Sci. 924, 62\u201367 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"104_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00429-009-0232-6","volume":"214","author":"L Crews","year":"2010","unstructured":"Crews, L., Rockenstein, E. & Masliah, E. APP transgenic modeling of Alzheimer\u2019s disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct. Funct. 214, 111\u2013126 (2010).","journal-title":"Brain Struct. Funct."},{"key":"104_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2006.04.017","volume":"24","author":"K Boekhoorn","year":"2006","unstructured":"Boekhoorn, K., Joels, M. & Lucassen, P. J. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol. Dis. 24, 1\u201314 (2006).","journal-title":"Neurobiol. Dis."},{"key":"104_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","volume":"67","author":"B Li","year":"2008","unstructured":"Li, B. et al. Failure of neuronal maturation in Alzheimer disease dentate gyrus. J. Neuropathol. Exp. Neurol. 67, 78\u201384 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"104_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.expneurol.2004.04.002","volume":"188","author":"PH Wen","year":"2004","unstructured":"Wen, P. H. et al. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp. Neurol. 188, 224\u2013237 (2004).","journal-title":"Exp. Neurol."},{"key":"104_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuroscience.2004.05.040","volume":"127","author":"H Dong","year":"2004","unstructured":"Dong, H. et al. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127, 601\u2013609 (2004).","journal-title":"Neuroscience"},{"key":"104_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0002-9440(10)62962-8","volume":"167","author":"NL Chevallier","year":"2005","unstructured":"Chevallier, N. L. et al. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am. J. Pathol. 167, 151\u2013159 (2005).","journal-title":"Am. J. Pathol."},{"key":"104_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"104_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/neur.1996.0056","volume":"5","author":"ST DeKosky","year":"1996","unstructured":"DeKosky, S. T., Scheff, S. W. & Styren, S. D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5, 417\u2013421 (1996).","journal-title":"Neurodegeneration"},{"key":"104_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0092-8674(89)90093-7","volume":"58","author":"DJ Selkoe","year":"1989","unstructured":"Selkoe, D. J. Amyloid \u03b2 protein precursor and the pathogenesis of Alzheimer\u2019s disease. Cell 58, 611\u2013612 (1989).","journal-title":"Cell"},{"key":"104_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1096\/fasebj.9.5.7896005","volume":"9","author":"SS Sisodia","year":"1995","unstructured":"Sisodia, S. S. & Price, D. L. Role of the \u03b2\u2010amyloid protein in Alzheimer\u2019s disease. FASEB J. 9, 366\u2013370 (1995).","journal-title":"FASEB J."},{"key":"104_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim, J., Basak, J. M. & Holtzman, D. M. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63, 287\u2013303 (2009).","journal-title":"Neuron"},{"key":"104_CR20","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata, N. et al. Metabolic regulation of brain A\u03b2 by neprilysin. Science 292, 1550\u20131552 (2001).","journal-title":"Science"},{"key":"104_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/jnen\/62.5.451","volume":"62","author":"J Bendiske","year":"2003","unstructured":"Bendiske, J. & Bahr, B. A. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis\u2014an approach for slowing Alzheimer disease? J. Neuropathol. Exp. Neurol. 62, 451\u2013463 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"104_CR22","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud, P., Zhao, H. & Davies, P. Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J. Biol. Chem. 280, 37377\u201337382 (2005).","journal-title":"J. Biol. Chem."},{"key":"104_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel, M. A. et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482, 216\u2013220 (2012).","journal-title":"Nature"},{"key":"104_CR24","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1038\/399a023","volume":"399","author":"DJ Selkoe","year":"1999","unstructured":"Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer\u2019s disease. Nature 399, A23\u2013A31 (1999).","journal-title":"Nature"},{"key":"104_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/0929866043407174","volume":"11","author":"DM Walsh","year":"2004","unstructured":"Walsh, D. M. & Selkoe, D. J. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 11, 213\u2013228 (2004).","journal-title":"Protein Pept. Lett."},{"key":"104_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"WL Klein","year":"2001","unstructured":"Klein, W. L., Krafft, G. A. & Finch, C. E. Targeting small A\u03b2 oligomers: the solution to an Alzheimer\u2019s disease conundrum? Trends Neurosci. 24, 219\u2013224 (2001).","journal-title":"Trends Neurosci."},{"key":"104_CR27","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.1068613","volume":"296","author":"MC Raff","year":"2002","unstructured":"Raff, M. C., Whitmore, A. V. & Finn, J. T. Axonal self-destruction and neurodegeneration. Science 296, 868\u2013871 (2002).","journal-title":"Science"},{"key":"104_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/JAD-2001-3117","volume":"3","author":"E Masliah","year":"2001","unstructured":"Masliah, E. Recent advances in the understanding of the role of synaptic proteins in Alzheimer\u2019s disease and other neurodegenerative disorders. J. Alzheimer\u2019s Dis. 3, 121\u2013129 (2001).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"104_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-2001-3509","volume":"3","author":"SW Scheff","year":"2001","unstructured":"Scheff, S. W. & Price, D. A. Alzheimer\u2019s disease-related synapse loss in the cingulate cortex. J. Alzheimer\u2019s Dis. 3, 495\u2013505 (2001).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"104_CR30","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 (2019)."},{"key":"104_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30, 350\u2013358 (2015).","journal-title":"Mov. Disord."},{"key":"104_CR32","doi-asserted-by":"publisher","first-page":"104268","DOI":"10.1016\/j.nbd.2018.09.001","volume":"135","author":"G Kong","year":"2020","unstructured":"Kong, G. et al. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease. Neurobiol. Dis. 135, 104268 (2020).","journal-title":"Neurobiol. Dis."},{"key":"104_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-1644-y","volume":"574","author":"C Chu","year":"2019","unstructured":"Chu, C. et al. The microbiota regulate neuronal function and fear extinction learning. Nature 574, 543\u2013548 (2019).","journal-title":"Nature"},{"key":"104_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","volume":"58","author":"C Jiang","year":"2017","unstructured":"Jiang, C., Li, G., Huang, P., Liu, Z. & Zhao, B. The gut microbiota and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 58, 1\u201315 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"104_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-181143","volume":"68","author":"L Shen","year":"2019","unstructured":"Shen, L. & Ji, H.-F. Associations between gut microbiota and Alzheimer\u2019s disease: current evidences and future therapeutic and diagnostic perspectives. J. Alzheimer\u2019s Dis. 68, 25\u201331 (2019).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"104_CR36","doi-asserted-by":"crossref","unstructured":"Ticinesi, A., Nouvenne, A., Tana, C., Prati, B. & Meschi, T. Gut microbiota and microbiota-related metabolites as possible biomarkers of cognitive aging. Adv. Exp. Med. Biol. 1178, 129\u2013154 (2019).","DOI":"10.1007\/978-3-030-25650-0_8"},{"key":"104_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","volume":"10","author":"SM Collins","year":"2012","unstructured":"Collins, S. M., Surette, M. & Bercik, P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735\u2013742 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"104_CR38","doi-asserted-by":"publisher","first-page":"ii68","DOI":"10.1093\/rheumatology\/kew353","volume":"55","author":"H Wekerle","year":"2016","unstructured":"Wekerle, H. The gut\u2013brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology 55, ii68\u2013ii75 (2016).","journal-title":"Rheumatology"},{"key":"104_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/nu10050591","volume":"10","author":"M Briguglio","year":"2018","unstructured":"Briguglio, M. et al. Dietary neurotransmitters: a narrative review on current knowledge. Nutrients 10, 591 (2018).","journal-title":"Nutrients"},{"key":"104_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro, V. & Edison, P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement. 12, 719\u2013732 (2016).","journal-title":"Alzheimers Dement."},{"key":"104_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","volume":"46","author":"TG Dinan","year":"2017","unstructured":"Dinan, T. G. & Cryan, J. F. The microbiome-gut-brain axis in health and disease. Gastroenterol. Clin. North Am. 46, 77\u201389 (2017).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"104_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz, B., Bazin, T. & Pellissier, S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front. Neurosci. 12, 49 (2018).","journal-title":"Front. Neurosci."},{"key":"104_CR43","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.4103\/0366-6999.190667","volume":"129","author":"HX Wang","year":"2016","unstructured":"Wang, H. X. & Wang, Y. P. Gut microbiota-brain axis. Chin. Med. J. 129, 2373\u20132380 (2016).","journal-title":"Chin. Med. J."},{"key":"104_CR44","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti, M., Scirocco, A., Maselli, M. A. & Severi, C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 28, 203\u2013209 (2015).","journal-title":"Ann. Gastroenterol."},{"key":"104_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1535370217743766","volume":"243","author":"AF Logsdon","year":"2018","unstructured":"Logsdon, A. F., Erickson, M. A., Rhea, E. M., Salameh, T. S. & Banks, W. A. Gut reactions: how the blood-brain barrier connects the microbiome and the brain. Exp. Biol. Med. 243, 159\u2013165 (2018).","journal-title":"Exp. Biol. Med."},{"key":"104_CR46","first-page":"543","volume":"10","author":"S Zac-Varghese","year":"2010","unstructured":"Zac-Varghese, S., Tan, T. & Bloom, S. R. Hormonal interactions between gut and brain. Discov. Med. 10, 543\u2013552 (2010).","journal-title":"Discov. Med."},{"key":"104_CR47","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","volume":"17","author":"L Galland","year":"2014","unstructured":"Galland, L. The gut microbiome and the brain. J. Med. Food 17, 1261\u20131272 (2014).","journal-title":"J. Med. Food"},{"key":"104_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ajmg.b.32567","volume":"174","author":"R Alam","year":"2017","unstructured":"Alam, R., Abdolmaleky, H. M. & Zhou, J. R. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am. J. Med. Genet. B Neuropsychiatr. Genet. 174, 651\u2013660 (2017).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"104_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41579-018-0014-3","volume":"16","author":"KV Johnson","year":"2018","unstructured":"Johnson, K. V. & Foster, K. R. Why does the microbiome affect behaviour? Nat. Rev. Microbiol. 16, 647\u2013655 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"104_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/gut.2009.202515","volume":"60","author":"MG Gareau","year":"2011","unstructured":"Gareau, M. G. et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307\u2013317 (2011).","journal-title":"Gut"},{"key":"104_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13311-017-0585-0","volume":"15","author":"G Lach","year":"2018","unstructured":"Lach, G., Schellekens, H., Dinan, T. G. & Cryan, J. F. Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 15, 36\u201359 (2018).","journal-title":"Neurotherapeutics"},{"key":"104_CR52","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s00415-018-8943-3","volume":"265","author":"HMH Braakman","year":"2018","unstructured":"Braakman, H. M. H. & van Ingen, J. Can epilepsy be treated by antibiotics? J. Neurol. 265, 1934\u20131936 (2018).","journal-title":"J. Neurol."},{"key":"104_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"Quigley, E. M. M. Microbiota-brain-gut axis and neurodegenerative diseases. Curr. Neurol. Neurosci. Rep. 17, 94 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"104_CR54","doi-asserted-by":"crossref","unstructured":"Kirby, T. O. & Ochoa-Rep\u00e1raz, J. The gut microbiome in multiple sclerosis: a potential therapeutic avenue. Med. Sci. 6, 69 (2018).","DOI":"10.3390\/medsci6030069"},{"key":"104_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella, M. et al. Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov. Disord. 34, 396\u2013405 (2019).","journal-title":"Mov. Disord."},{"key":"104_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo, A. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49, 60\u201368 (2017).","journal-title":"Neurobiol. Aging"},{"key":"104_CR57","doi-asserted-by":"publisher","first-page":"e00632","DOI":"10.1128\/mBio.00632-19","volume":"10","author":"JP Haran","year":"2019","unstructured":"Haran, J. P. et al. Alzheimer\u2019s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. mBio 10, e00632\u201300619 (2019).","journal-title":"mBio"},{"key":"104_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19393-0","volume":"12","author":"A Kaiyrlykyzy","year":"2022","unstructured":"Kaiyrlykyzy, A. et al. Study of gut microbiota alterations in Alzheimer\u2019s dementia patients from Kazakhstan. Sci. Rep. 12, 15115 (2022).","journal-title":"Sci. Rep."},{"key":"104_CR59","doi-asserted-by":"crossref","unstructured":"Zhu, Z. et al. Altered gut microbiota and its clinical relevance in mild cognitive impairment and Alzheimer\u2019s disease: Shanghai Aging Study and Shanghai Memory Study. Nutrients 14, 3959 (2022).","DOI":"10.3390\/nu14193959"},{"key":"104_CR60","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","volume":"56","author":"M Sochocka","year":"2019","unstructured":"Sochocka, M. et al. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer\u2019s disease\u2014a critical review. Mol. Neurobiol. 56, 1841\u20131851 (2019).","journal-title":"Mol. Neurobiol."},{"key":"104_CR61","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761\u20131772 (2007).","journal-title":"Diabetes"},{"key":"104_CR62","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","volume":"7","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y., Jaber, V. & Lukiw, W. J. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer\u2019s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front. Cell. Infect. Microbiol. 7, 318 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"104_CR63","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3389\/fimmu.2017.01064","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y., Cong, L., Jaber, V. & Lukiw, W. J. Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer\u2019s disease brain. Front. Immunol. 8, 1064 (2017).","journal-title":"Front. Immunol."},{"key":"104_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1203\/00006450-200001000-00013","volume":"47","author":"Z Cai","year":"2000","unstructured":"Cai, Z., Pan, Z. L., Pang, Y., Evans, O. B. & Rhodes, P. G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47, 64\u201372 (2000).","journal-title":"Pediatr. Res."},{"key":"104_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/JAD-131394","volume":"39","author":"A Asti","year":"2014","unstructured":"Asti, A. & Gioglio, L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimers. Dis. 39, 169\u2013179 (2014).","journal-title":"J. Alzheimers. Dis."},{"key":"104_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0969-9961(03)00069-X","volume":"14","author":"JG Sheng","year":"2003","unstructured":"Sheng, J. G. et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133\u2013145 (2003).","journal-title":"Neurobiol. Dis."},{"key":"104_CR67","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan, X. et al. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87, 2324\u20132332 (2016).","journal-title":"Neurology"},{"key":"104_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnins.2019.00113","volume":"13","author":"C Hewel","year":"2019","unstructured":"Hewel, C. et al. Common miRNA patterns of Alzheimer\u2019s disease and Parkinson\u2019s disease and their putative impact on commensal gut microbiota. Front. Neurosci. 13, 113 (2019).","journal-title":"Front. Neurosci."},{"key":"104_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fneur.2018.00145","volume":"9","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. & Lukiw, W. J. Microbiome-mediated upregulation of microRNA-146a in sporadic Alzheimer\u2019s disease. Front. Neurol. 9, 145 (2018).","journal-title":"Front. Neurol."},{"key":"104_CR70","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5114\/fn.2019.88449","volume":"57","author":"P Alexandrov","year":"2019","unstructured":"Alexandrov, P., Zhai, Y., Li, W. & Lukiw, W. Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain. Folia Neuropathol. 57, 211\u2013219 (2019).","journal-title":"Folia Neuropathol."},{"key":"104_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep41802","volume":"7","author":"T Harach","year":"2017","unstructured":"Harach, T. et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 7, 41802 (2017).","journal-title":"Sci. Rep."},{"key":"104_CR72","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066\u20139071 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"104_CR73","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00702-015-1381-9","volume":"122","author":"F Leblhuber","year":"2015","unstructured":"Leblhuber, F., Geisler, S., Steiner, K., Fuchs, D. & Sch\u00fctz, B. Elevated fecal calprotectin in patients with Alzheimer\u2019s dementia indicates leaky gut. J. Neural Transm. 122, 1319\u20131322 (2015).","journal-title":"J. Neural Transm."},{"key":"104_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ame2.12033","volume":"1","author":"Z Li","year":"2018","unstructured":"Li, Z., Zhu, H., Zhang, L. & Qin, C. The intestinal microbiome and Alzheimer\u2019s disease: a review. Animal Model Exp. Med. 1, 180\u2013188 (2018).","journal-title":"Animal Model Exp. Med."},{"key":"104_CR75","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.1108750","volume":"308","author":"FW Turek","year":"2005","unstructured":"Turek, F. W. et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308, 1043\u20131045 (2005).","journal-title":"Science"},{"key":"104_CR76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1210\/er.2017-00193","volume":"39","author":"O Froy","year":"2018","unstructured":"Froy, O. & Garaulet, M. The circadian clock in white and brown adipose tissue: mechanistic, endocrine, and clinical aspects. Endocr. Rev. 39, 261\u2013273 (2018).","journal-title":"Endocr. Rev."},{"key":"104_CR77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lfs.2019.04.006","volume":"225","author":"W Ma","year":"2019","unstructured":"Ma, W. et al. Chronic paradoxical sleep deprivation-induced depressionlike behavior, energy metabolism and microbial changes in rats. Life Sci. 225, 88\u201397 (2019).","journal-title":"Life Sci."},{"key":"104_CR78","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/pcn.12688","volume":"72","author":"Y Takaesu","year":"2018","unstructured":"Takaesu, Y. Circadian rhythm in bipolar disorder: a review of the literature. Psychiatry Clin. Neurosci. 72, 673\u2013682 (2018).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"104_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fmed.2016.00073","volume":"3","author":"M Canevelli","year":"2016","unstructured":"Canevelli, M. et al. Sundowning in dementia: clinical relevance, pathophysiological determinants, and therapeutic approaches. Front. Med. 3, 73 (2016).","journal-title":"Front. Med."},{"key":"104_CR80","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0092-8674(00)00205-1","volume":"103","author":"MK Bunger","year":"2000","unstructured":"Bunger, M. K. et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103, 1009\u20131017 (2000).","journal-title":"Cell"},{"key":"104_CR81","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2019.05.009","volume":"177","author":"PS Welz","year":"2019","unstructured":"Welz, P. S. et al. BMAL1-driven tissue clocks respond independently to light to maintain homeostasis. Cell 177, 1436\u20131447.e1412 (2019).","journal-title":"Cell"},{"key":"104_CR82","doi-asserted-by":"publisher","first-page":"R1053","DOI":"10.1152\/ajpregu.00066.2013","volume":"304","author":"J Richards","year":"2013","unstructured":"Richards, J. & Gumz, M. L. Mechanism of the circadian clock in physiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R1053\u2013R1064 (2013).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"104_CR83","doi-asserted-by":"crossref","unstructured":"Peng, X. et al. A growing link between circadian rhythms, type 2 diabetes mellitus and Alzheimer\u2019s disease. Int. J. Mol. Sci. 23, 504 (2022).","DOI":"10.3390\/ijms23010504"},{"key":"104_CR84","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41580-018-0096-9","volume":"20","author":"H Reinke","year":"2019","unstructured":"Reinke, H. & Asher, G. Crosstalk between metabolism and circadian clocks. Nat. Rev. Mol. Cell Biol. 20, 227\u2013241 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"104_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","volume":"15","author":"DJ Stenvers","year":"2019","unstructured":"Stenvers, D. J., Scheer, F., Schrauwen, P., la Fleur, S. E. & Kalsbeek, A. Circadian clocks and insulin resistance. Nat. Rev. Endocrinol. 15, 75\u201389 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"104_CR86","doi-asserted-by":"crossref","unstructured":"Chhunchha, B., Kubo, E. & Singh, D. P. Clock protein Bmal1 and Nrf2 cooperatively control aging or oxidative response and redox homeostasis by regulating rhythmic expression of Prdx6. Cells 9, 1861 (2020).","DOI":"10.3390\/cells9081861"},{"key":"104_CR87","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1161\/CIRCRESAHA.119.315502","volume":"126","author":"M Xie","year":"2020","unstructured":"Xie, M. et al. BMAL1-downregulation aggravates Porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress. Circ. Res. 126, e15\u2013e29 (2020).","journal-title":"Circ. Res."},{"key":"104_CR88","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1096\/fj.201901565RR","volume":"34","author":"WW Liu","year":"2020","unstructured":"Liu, W. W. et al. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson\u2019s disease mouse model. FASEB J. 34, 6570\u20136581 (2020).","journal-title":"FASEB J."},{"key":"104_CR89","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cub.2013.01.048","volume":"23","author":"SQ Shi","year":"2013","unstructured":"Shi, S. Q., Ansari, T. S., McGuinness, O. P., Wasserman, D. H. & Johnson, C. H. Circadian disruption leads to insulin resistance and obesity. Curr. Biol. 23, 372\u2013381 (2013).","journal-title":"Curr. Biol."},{"key":"104_CR90","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nature09253","volume":"466","author":"B Marcheva","year":"2010","unstructured":"Marcheva, B. et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466, 627\u2013631 (2010).","journal-title":"Nature"},{"key":"104_CR91","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.aah4968","volume":"354","author":"ES Musiek","year":"2016","unstructured":"Musiek, E. S. & Holtzman, D. M. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science 354, 1004\u20131008 (2016).","journal-title":"Science"},{"key":"104_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tem.2016.02.003","volume":"27","author":"J Mattis","year":"2016","unstructured":"Mattis, J. & Sehgal, A. Circadian rhythms, sleep, and disorders of aging. Trends Endocrinol. Metab. 27, 192\u2013203 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"104_CR93","doi-asserted-by":"publisher","first-page":"e13704","DOI":"10.1111\/acel.13704","volume":"21","author":"R Fan","year":"2022","unstructured":"Fan, R. et al. Importance of Bmal1 in Alzheimer\u2019s disease and associated aging-related diseases: mechanisms and interventions. Aging Cell 21, e13704 (2022).","journal-title":"Aging Cell"},{"key":"104_CR94","doi-asserted-by":"publisher","first-page":"18515","DOI":"10.4238\/2015.December.23.39","volume":"14","author":"Q Chen","year":"2015","unstructured":"Chen, Q., Peng, X. D., Huang, C. Q., Hu, X. Y. & Zhang, X. M. Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population. Genet. Mol. Res. 14, 18515\u201318522 (2015).","journal-title":"Genet. Mol. Res."},{"key":"104_CR95","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.3390\/ijms21217862","volume":"21","author":"ID Yoo","year":"2020","unstructured":"Yoo, I. D. Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 7862 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"104_CR96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0748730410395732","volume":"26","author":"N Cermakian","year":"2011","unstructured":"Cermakian, N., Lamont, E. W., Boudreau, P. & Boivin, D. B. Circadian clock gene expression in brain regions of Alzheimer\u2019s disease patients and control subjects. J. Biol. Rhythms 26, 160\u2013170 (2011).","journal-title":"J. Biol. Rhythms"},{"key":"104_CR97","doi-asserted-by":"publisher","first-page":"4854732","DOI":"10.1155\/2018\/4854732","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 pathway in 6-OHDA-induced models of Parkinson\u2019s disease. Oxid. Med. Cell. Longev. 2018, 4854732 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"104_CR98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-015-0007-x","volume":"10","author":"H Song","year":"2015","unstructured":"Song, H. et al. A\u03b2-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer\u2019s disease. Mol. Neurodegener. 10, 13 (2015).","journal-title":"Mol. Neurodegener."},{"key":"104_CR99","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1084\/jem.20172347","volume":"215","author":"GJ Kress","year":"2018","unstructured":"Kress, G. J. et al. Regulation of amyloid-\u03b2 dynamics and pathology by the circadian clock. J. Exp. Med. 215, 1059\u20131068 (2018).","journal-title":"J. Exp. Med."},{"key":"104_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05862-z","volume":"12","author":"CA McKee","year":"2022","unstructured":"McKee, C. A. et al. Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden. Sci. Rep. 12, 1796 (2022).","journal-title":"Sci. Rep."},{"key":"104_CR101","doi-asserted-by":"publisher","first-page":"e13078","DOI":"10.1111\/acel.13078","volume":"19","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer\u2019s disease. Aging Cell 19, e13078 (2020).","journal-title":"Aging Cell"},{"key":"104_CR102","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/glia.23754","volume":"68","author":"AAH Ali","year":"2020","unstructured":"Ali, A. A. H. et al. Bmal1-deficiency affects glial synaptic coverage of the hippocampal mossy fiber synapse and the actin cytoskeleton in astrocytes. Glia 68, 947\u2013962 (2020).","journal-title":"Glia"},{"key":"104_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14336","volume":"8","author":"O Barca-Mayo","year":"2017","unstructured":"Barca-Mayo, O. et al. Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling. Nat. Commun. 8, 14336 (2017).","journal-title":"Nat. Commun."},{"key":"104_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.09.015","volume":"25","author":"BV Lananna","year":"2018","unstructured":"Lananna, B. V. et al. Cell-autonomous regulation of astrocyte activation by the circadian clock protein BMAL1. Cell Rep. 25, 1\u20139.e5 (2018).","journal-title":"Cell Rep."},{"key":"104_CR105","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1172\/JCI70317","volume":"123","author":"ES Musiek","year":"2013","unstructured":"Musiek, E. S. et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J. Clin. Invest. 123, 5389\u20135400 (2013).","journal-title":"J. Clin. Invest."},{"key":"104_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26547-6","volume":"8","author":"A Hadar","year":"2018","unstructured":"Hadar, A. et al. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer\u2019s disease. Sci. Rep. 8, 8465 (2018).","journal-title":"Sci. Rep."},{"key":"104_CR107","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2008.06.050","volume":"134","author":"G Asher","year":"2008","unstructured":"Asher, G. et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134, 317\u2013328 (2008).","journal-title":"Cell"},{"key":"104_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1074\/jbc.M107850200","volume":"277","author":"K Sanada","year":"2002","unstructured":"Sanada, K., Okano, T. & Fukada, Y. Mitogen-activated protein kinase phosphorylates and negatively regulates basic helix-loop-helix-PAS transcription factor BMAL1. J. Biol. Chem. 277, 267\u2013271 (2002).","journal-title":"J. Biol. Chem."},{"key":"104_CR109","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10571-022-01191-x","volume":"43","author":"MR Khezri","year":"2023","unstructured":"Khezri, M. R., Yousefi, K., Esmaeili, A. & Ghasemnejad-Berenji, M. The role of ERK1\/2 pathway in the pathophysiology of Alzheimer\u2019s disease: an overview and update on new developments. Cell. Mol. Neurobiol. 43, 177\u2013191 (2023).","journal-title":"Cell. Mol. Neurobiol."},{"key":"104_CR110","doi-asserted-by":"publisher","first-page":"e8561","DOI":"10.1371\/journal.pone.0008561","volume":"5","author":"S Sahar","year":"2010","unstructured":"Sahar, S., Zocchi, L., Kinoshita, C., Borrelli, E. & Sassone-Corsi, P. Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS ONE 5, e8561 (2010).","journal-title":"PLoS ONE"},{"key":"104_CR111","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cell.2014.09.048","volume":"159","author":"CA Thaiss","year":"2014","unstructured":"Thaiss, C. A. et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 159, 514\u2013529 (2014).","journal-title":"Cell"},{"key":"104_CR112","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1073\/pnas.1501305112","volume":"112","author":"X Liang","year":"2015","unstructured":"Liang, X., Bushman, F. D. & FitzGerald, G. A. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc. Natl Acad. Sci. USA 112, 10479\u201310484 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"104_CR113","doi-asserted-by":"publisher","first-page":"160041","DOI":"10.1016\/j.scitotenv.2022.160041","volume":"858","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Reducing light exposure enhances the circadian rhythm of the biological clock through interactions with the gut microbiota. Sci. Total Environ. 858, 160041 (2023).","journal-title":"Sci. Total Environ."},{"key":"104_CR114","doi-asserted-by":"publisher","first-page":"eabk2541","DOI":"10.1126\/sciimmunol.abk2541","volume":"7","author":"HA Penny","year":"2022","unstructured":"Penny, H. A. et al. Rhythmicity of intestinal IgA responses confers oscillatory commensal microbiota mutualism. Sci. Immunol. 7, eabk2541 (2022).","journal-title":"Sci. Immunol."},{"key":"104_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13195-022-01062-z","volume":"14","author":"D Pocevi\u010di\u016bt\u0117","year":"2022","unstructured":"Pocevi\u010di\u016bt\u0117, D. et al. Increased plasma and brain immunoglobulin A in Alzheimer\u2019s disease is lost in apolipoprotein E \u03b54 carriers. Alzheimer\u2019s Res. Ther. 14, 117 (2022).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"104_CR116","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/11533070-000000000-00000","volume":"70","author":"R Dodel","year":"2010","unstructured":"Dodel, R. et al. Intravenous immunoglobulins as a treatment for Alzheimer\u2019s disease. Drugs 70, 513\u2013528 (2010).","journal-title":"Drugs"},{"key":"104_CR117","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.neuron.2020.09.002","volume":"108","author":"RS Pulido","year":"2020","unstructured":"Pulido, R. S. et al. Neuronal activity regulates blood-brain barrier efflux transport through endothelial circadian genes. Neuron 108, 937\u2013952. e937 (2020).","journal-title":"Neuron"},{"key":"104_CR118","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2020.05.077","volume":"89","author":"F Medina-Flores","year":"2020","unstructured":"Medina-Flores, F. et al. Sleep loss disrupts pericyte-brain endothelial cell interactions impairing blood-brain barrier function. Brain Behav. Immun. 89, 118\u2013132 (2020).","journal-title":"Brain Behav. Immun."},{"key":"104_CR119","doi-asserted-by":"publisher","first-page":"111560","DOI":"10.1016\/j.mad.2021.111560","volume":"199","author":"S Liu","year":"2021","unstructured":"Liu, S., Gao, J., Liu, K. & Zhang, H. L. Microbiota-gut-brain axis and Alzheimer\u2019s disease: implications of the blood-brain barrier as an intervention target. Mech. Ageing Dev. 199, 111560 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"104_CR120","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.phrs.2018.06.011","volume":"134","author":"B Vincent","year":"2018","unstructured":"Vincent, B. Protective roles of melatonin against the amyloid-dependent development of Alzheimer\u2019s disease: a critical review. Pharmacol. Res. 134, 223\u2013237 (2018).","journal-title":"Pharmacol. Res."},{"key":"104_CR121","doi-asserted-by":"publisher","first-page":"e12574","DOI":"10.1111\/jpi.12574","volume":"67","author":"T Gao","year":"2019","unstructured":"Gao, T. et al. Role of melatonin in sleep deprivation\u2010induced intestinal barrier dysfunction in mice. J. Pineal Res. 67, e12574 (2019).","journal-title":"J. Pineal Res."},{"key":"104_CR122","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.chom.2015.03.006","volume":"17","author":"V Leone","year":"2015","unstructured":"Leone, V. et al. Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 17, 681\u2013689 (2015).","journal-title":"Cell Host Microbe"}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-023-00104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-023-00104-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-023-00104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:08:35Z","timestamp":1683025715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-023-00104-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1038\/s41514-023-00104-6","relation":{},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"2 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}